BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 7, 2014
View Archived Issues
Novel GLP-1 agonist TTP-273 reduces glucose levels in type 2 diabetes patients
Read More
Manganese porphyrin antioxidant ameliorates experimental type 2 diabetes
Read More
Kyowa Hakko Kirin to start new phase II study of bardoxolone methyl
Read More
Amarantus announces toxicology data for MANF in retinitis pigmentosa
Read More
Jazz Pharmaceuticals gains rights to Defitelio in the Americas from Sigma-Tau
Read More
Synchroneuron's development of SNC-102 supported by Series B funding
Read More
Novel beta2-adrenoceptor agonists for the treatment of respiratory disorders
Read More
Voltage-gated calcium channels, potential targets for chronic pain
Read More
AVEO Pharmaceuticals discloses novel anti-FGFR-2 MAbs
Read More
AIMM Therapeutics to receive milestone payment
Read More
First patients dosed in a phase II trial of the novel antibiotic SMT-19969
Read More
Dual calcitonin and amylin receptor agonists show potential for obesity, diabetes and osteoarthritis
Read More
Dermira licenses Cimzia for psoriasis
Read More
Novel nonsense mutation suppressors patented by Novartis
Read More
Cellceutix designs novel agents for bacterial infections and cancer
Read More
Sumitomo Dainippon Pharma discloses new 5-HT4 receptor agonists
Read More
Roche discloses novel BTK inhibitors
Read More
Aegis Therapeutics seeks to out-license octreotide nasal spray
Read More
Glenmark's GBR-830 enters human trials for autoimmune diseases
Read More
Teva Pharmaceutical receives positive CHMP opinion for Seasonique
Read More
Japanese approval of Alecensa for ALK-positive NSCLC
Read More
Nivolumab, the first drug targeting PD-1 approved
Read More
Japanese approval for biosimilar infliximab
Read More
European approval for Arzerra in first-line treatment of CLL
Read More
Kitasato Daiichi Sankyo Vaccine obtains pertussis-diphtheria-tetanus-polio vaccine licenses
Read More
Deltyba approved in Japan for multidrug-resistant tuberculosis
Read More
Canagliflozin approved in Japan for type 2 diabetes
Read More